5-131171033-G-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_181705.4(LYRM7):ā€‹c.13G>Cā€‹(p.Val5Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000724 in 1,382,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 7.2e-7 ( 0 hom. )

Consequence

LYRM7
NM_181705.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.48
Variant links:
Genes affected
LYRM7 (HGNC:28072): (LYR motif containing 7) Inner mitochondrial membrane complex III (CIII) is the main enzyme complex in the mitochondrial respiratory chain, and Rieske Fe-S protein (UQCRFS1) is the last catalytic subunit added to the complex. The protein encoded by this gene is a nuclear-encoded mitochondrial matrix protein that stabilizes UQCRFS1 and chaperones it to the CIII complex. Defects in this gene are a cause of mitochondrial complex III deficiency, nuclear type 8. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]
HINT1 (HGNC:4912): (histidine triad nucleotide binding protein 1) This gene encodes a protein that hydrolyzes purine nucleotide phosphoramidates substrates, including AMP-morpholidate, AMP-N-alanine methyl ester, AMP-alpha-acetyl lysine methyl ester, and AMP-NH2. The encoded protein interacts with these substrates via a histidine triad motif. This gene is considered a tumor suppressor gene. In addition, mutations in this gene can cause autosomal recessive neuromyotonia and axonal neuropathy. There are several related pseudogenes on chromosome 7. Several transcript variants have been observed. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04101792).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LYRM7NM_181705.4 linkuse as main transcriptc.13G>C p.Val5Leu missense_variant 1/5 ENST00000379380.9
LYRM7NM_001293735.2 linkuse as main transcriptc.13G>C p.Val5Leu missense_variant 1/4
LYRM7NR_121658.2 linkuse as main transcriptn.90G>C non_coding_transcript_exon_variant 1/3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LYRM7ENST00000379380.9 linkuse as main transcriptc.13G>C p.Val5Leu missense_variant 1/51 NM_181705.4 P1
LYRM7ENST00000507584.1 linkuse as main transcriptc.13G>C p.Val5Leu missense_variant 1/42
LYRM7ENST00000510516.5 linkuse as main transcriptc.13G>C p.Val5Leu missense_variant 1/32
HINT1ENST00000506207.2 linkuse as main transcriptn.236+573C>G intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.24e-7
AC:
1
AN:
1382078
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
685566
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.24e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 15, 2022The c.13G>C (p.V5L) alteration is located in exon 1 (coding exon 1) of the LYRM7 gene. This alteration results from a G to C substitution at nucleotide position 13, causing the valine (V) at amino acid position 5 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
13
DANN
Benign
0.64
DEOGEN2
Benign
0.0068
T;.;.
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.65
FATHMM_MKL
Benign
0.42
N
LIST_S2
Benign
0.48
T;T;T
M_CAP
Benign
0.0013
T
MetaRNN
Benign
0.041
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.8
N;.;.
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.45
T
PROVEAN
Benign
0.92
N;N;N
REVEL
Benign
0.089
Sift
Benign
0.72
T;D;T
Sift4G
Benign
0.61
T;T;T
Polyphen
0.0
B;.;.
Vest4
0.084
MutPred
0.25
Loss of methylation at K6 (P = 0.039);Loss of methylation at K6 (P = 0.039);Loss of methylation at K6 (P = 0.039);
MVP
0.030
MPC
0.040
ClinPred
0.067
T
GERP RS
3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.094
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1368424392; hg19: chr5-130506726; API